These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19221477)

  • 1. Chromosome 1q gain is not associated with a poor outcome in childhood medulloblastoma: requirements for the validation of potential prognostic biomarkers.
    Clifford SC; O'Toole K; Ellison DW
    Cell Cycle; 2009 Mar; 8(5):787. PubMed ID: 19221477
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.
    McCabe MG; Bäcklund LM; Leong HS; Ichimura K; Collins VP
    Neuro Oncol; 2011 Apr; 13(4):376-83. PubMed ID: 21292688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
    Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
    J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
    Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
    Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.
    Bien-Willner GA; López-Terrada D; Bhattacharjee MB; Patel KU; Stankiewicz P; Lupski JR; Pfeifer JD; Perry A
    Neuro Oncol; 2012 Jul; 14(7):831-40. PubMed ID: 22573308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system.
    Schofield DE; Yunis EJ; Geyer JR; Albright AL; Berger MS; Taylor SR
    Cancer; 1992 Mar; 69(5):1307-14. PubMed ID: 1739930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of cerebellar medulloblastoma with a single chromosome abnormality.
    Stratton MR; Darling J; Cooper CS; Reeves BR
    Cancer Genet Cytogenet; 1991 May; 53(1):101-3. PubMed ID: 2036631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic risk stratification of medulloblastoma: the real time is now.
    Fisher PG; Burger PC; Eberhart CG
    J Clin Oncol; 2004 Mar; 22(6):971-4. PubMed ID: 14970187
    [No Abstract]   [Full Text] [Related]  

  • 9. FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma.
    Ramaswamy V; Northcott PA; Taylor MD
    Cancer Genet; 2011 Nov; 204(11):577-88. PubMed ID: 22200083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
    Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
    J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in medulloblastoma, including DNA ploidy.
    Zerbini C; Gelber RD; Weinberg D; Sallan SE; Barnes P; Kupsky W; Scott RM; Tarbell NJ
    J Clin Oncol; 1993 Apr; 11(4):616-22. PubMed ID: 8478656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.
    Rutkowski S; von Hoff K; Emser A; Zwiener I; Pietsch T; Figarella-Branger D; Giangaspero F; Ellison DW; Garre ML; Biassoni V; Grundy RG; Finlay JL; Dhall G; Raquin MA; Grill J
    J Clin Oncol; 2010 Nov; 28(33):4961-8. PubMed ID: 20940197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 9q and 16q loss identified by genome-wide pooled-analysis are associated with tumor aggressiveness in patients with classic medulloblastoma.
    Coco S; Valdora F; Bonassi S; Scaruffi P; Stigliani S; Oberthuer A; Berthold F; Andolfo I; Servidei T; Riccardi R; Basso E; Iolascon A; Tonini GP
    OMICS; 2011 May; 15(5):273-80. PubMed ID: 21348762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-MYC expression in medulloblastoma and its prognostic value.
    Herms J; Neidt I; Lüscher B; Sommer A; Schürmann P; Schröder T; Bergmann M; Wilken B; Probst-Cousin S; Hernáiz-Driever P; Behnke J; Hanefeld F; Pietsch T; Kretzschmar HA
    Int J Cancer; 2000 Sep; 89(5):395-402. PubMed ID: 11008200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of medulloblastoma in children under age of three years.
    Ryzhova MV; Zheludkova OG; Kumirova ÉV; Shishkina LV; Panina TN; Gorelyshev SK; Khukhlaeva EA; Mazerkina NA; Matuev KB; Medvedeva OA; Tarasova EM; Kholodov BV; Kapitul'skaia OIu
    Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(1):3-10; discussion 11. PubMed ID: 23659115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor genes and medulloblastoma.
    Cogen PH; McDonald JD
    J Neurooncol; 1996 Jul; 29(1):103-12. PubMed ID: 8817421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ploidy and proliferative index in medulloblastoma: useful prognostic factors?
    Tait DM; Eeles RA; Carter R; Ashley S; Ormerod MG
    Eur J Cancer; 1993; 29A(10):1383-7. PubMed ID: 8398263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.